Our comprehensive analysis, using bioinformatics tools and experimental validations, revealed distinct expression profiles of RBP family members across various cancers, highlighting the critical role of RBP4 and RBP7 in the context of triple-negative breast cancer biology. The gene discussed is RBP7; the disease is triple-negative breast carcinoma.